FBXW11
protein-codingF-box and WD repeat domain containing 11, the group of F-box and WD repeat domain containing|WD repeat domain containing
Gene summary
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class and, in addition to an F-box, contains multiple WD40 repeats. This gene contains at least 14 exons, and its alternative splicing generates 3 transcript variants diverging at the presence/absence of two alternate exons. [provided by RefSeq, Jul 2008]
- FBXW1B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~145.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030057
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0030057
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0030057
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0030057
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0030057
Submitter: Illumina
The FBXW11 gene is located on chromosome 5 at 5q35.1 and encodes the F-box and WD repeat domain containing 11 protein. This F-box protein functions as part of a ubiquitin ligase complex and is involved in ubiquitin-mediated protein degradation. FBSW11 also participates in the Wnt/β-catenin and Hh signalling pathways, which play critical roles in early embryonic development and tissue patterning. FBXW11 was first reported in relation to autosomal dominant FBXW11-related neurodevelopmental, brain, jaw, eye and digital anomalies in 2019 (31402090: Holt et al. 2019). Evidence supporting this gene-disease relationship includes case-level data and expereimental data. Seven unique heterozygous missense variants in this gene have been reported in seven individuals in a single cross-institutional publication (31402090: Holt et al. 2019). All variants occurred de novo. The maximum score for genetic evidence (12 pts) has been reached. Structural analyses indicated the variants clustered at the surface of the substrate-binding domain of FBXW11 and were predicted to destabilize the protein and/or its interactions, but the mechansim of disease has not yet been definitively determined. This gene-disease relationship is also supported by the gene's role in the Hh and Wnt/β-catenin signalling pathways, in which multiple genes have been linked to similar clinical phenotypes, tissue expression in the clinically affected systems in both humans and zebrafish, and a zebrafish knockdown model that shows eye, jaw, and pectoral fin anomalies that correlate with the phenotypes observed in humans (31402090: Holt et al. 2019). In summary, there is strong evidence to support the relationship between FBXW11 and autosomal dominant neurodevelopmental, brain, eye, and digit anomalies. Additional reports in humans published three years from the first proposal of the association are needed to reach a definitive classification.
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FBXW11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001378974.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 9 | |||
| missense | 1 | 10 | 99 | 1 | 111 | |
| nonsense | 10 | 10 | ||||
| start loss | 0 | |||||
| frameshift | 11 | 11 | ||||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 1 | 10 | 128 | 9 | 0 | 148 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001365903.1 | 13 | MANE Select | |
| Ensembl | ENSP00000428753.2 | 13 | MANE Select | |
| RefSeq | NP_001365904.1 | 12 | Standard | |
| RefSeq | NP_001365905.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Circadian rhythm - Homo sapiens (human)
- Oocyte meiosis - Homo sapiens (human)
- Ubiquitin mediated proteolysis - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Shigellosis - Homo sapiens (human)
Biological Process
- G2/M transition of mitotic cell cycle
- protein polyubiquitination
- protein dephosphorylation
- Wnt signaling pathway
- protein ubiquitination
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- protein dimerization activity
- ubiquitin protein ligase activity
Cellular Component
- ubiquitin ligase complex
- nucleus
- centrosome
- cytosol
- SCF ubiquitin ligase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265094
- Coding exons
- 12
- Length
- 145325
- Individuals with no LoFs
- 125729
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125735
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.96 | 115 | 312 | 0.369 | 0.0000179 | 3539 |
| Missense (PolyPhen) | 21 | 121.22 | 0.17324 | 1380 | ||
| Synonymous | 0.392 | 107 | 112 | 0.953 | 0.00000595 | 1024 |
| Loss of Function | 4.56 | 5 | 33.5 | 0.149 | 0.00000195 | 369 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000027 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins. SCF(FBXW11) mediates the ubiquitination of phosphorylated CTNNB1 and participates in Wnt signaling. SCF(FBXW11) mediates the ubiquitination of phosphorylated NFKBIA, which degradation frees the associated NFKB1 to translocate into the nucleus and to activate transcription. SCF(FBXW11) mediates the ubiquitination of IFNAR1. SCF(FBXW11) mediates the ubiquitination of CEP68; this is required for centriole separation during mitosis (PubMed:25503564). Involved in the oxidative stress-induced a ubiquitin-mediated decrease in RCAN1. Mediates the degradation of CDC25A induced by ionizing radiation in cells progressing through S phase and thus may function in the intra-S- phase checkpoint. Has an essential role in the control of the clock-dependent transcription via degradation of phosphorylated PER1 and phosphorylated PER2. SCF(FBXW11) mediates the ubiquitination of CYTH1, and probably CYTH2 (PubMed:29420262). {ECO:0000269|PubMed:10321728, ECO:0000269|PubMed:10437795, ECO:0000269|PubMed:10644755, ECO:0000269|PubMed:10648623, ECO:0000269|PubMed:14532120, ECO:0000269|PubMed:14603323, ECO:0000269|PubMed:15917222, ECO:0000269|PubMed:18575781, ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:20347421, ECO:0000269|PubMed:25503564, ECO:0000269|PubMed:29420262}.;
Recessive Scores
- pRec
- 0.160
Intolerance Scores
- LoFtool
- 0.354
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.04
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.996
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |